CCL5 and systemic lupus erythematosus: In contrast, CCL5 levels were 34.30% higher in patients with SLE compared with controls (<i>p</i> = 0.013), with the strongest increase observed in the inactive disease subgroup as compared to controls (by 40.29%, <i>p</i> = 0.021).